Vidas versus lucros

NOVA IORQUE – O Supremo Tribunal dos Estados Unidos iniciou recentemente as deliberações num caso que dá destaque a uma questão profundamente problemática, relativa aos direitos de propriedade intelectual. O Tribunal deve responder à seguinte pergunta: Podem os genes humanos - os seus genes - ser patenteados? Por outras palavras, deveria alguém ter essencialmente permissão para possuir o direito de, digamos, testar se você tem um conjunto de genes que implica uma probabilidade superior a 50% de desenvolver cancro da mama?

Para aqueles que não fazem parte do mundo misterioso dos direitos de propriedade intelectual, a resposta parece óbvia: Não. Você é o proprietário dos seus genes. Uma empresa pode possuir, no máximo, a propriedade intelectual subjacente ao seu teste genético e, uma vez que a investigação e o desenvolvimento necessários para desenvolver o teste podem ter custado um montante considerável, a empresa pode cobrar devidamente para administrá-lo.

Mas uma empresa sediada no Utah, Myriad Genetics, reivindica mais do que isso. Reivindica possuir os direitos de qualquer teste para detectar a presença de dois genes críticos associados ao cancro da mama - e tem executado impiedosamente esse direito, embora o seu teste seja inferior ao que a Universidade Yale estava disposta a fornecer a um custo muito menor. As consequências têm sido trágicas: A realização de testes minuciosos, a preços acessíveis, que identificam pacientes de alto risco, salva vidas. Bloquear tal realização de testes custa vidas. A Myriad é um verdadeiro exemplo de uma empresa norte-americana para a qual os lucros superam todos os outros valores, incluindo o valor da própria vida humana.

To continue reading, please log in or enter your email address.

Registration is quick and easy and requires only your email address. If you already have an account with us, please log in. Or subscribe now for unlimited access.

required

Log in

http://prosyn.org/cEzpfEE/pt;
  1. Chris J Ratcliffe/Getty Images

    The Brexit Surrender

    European Union leaders meeting in Brussels have given the go-ahead to talks with Britain on post-Brexit trade relations. But, as European Council President Donald Tusk has said, the most difficult challenge – forging a workable deal that secures broad political support on both sides – still lies ahead.

  2. The Great US Tax Debate

    ROBERT J. BARRO vs. JASON FURMAN & LAWRENCE H. SUMMERS on the impact of the GOP tax  overhaul.


    • Congressional Republicans are finalizing a tax-reform package that will reshape the business environment by lowering the corporate-tax rate and overhauling deductions. 

    • But will the plan's far-reaching changes provide the boost to investment and growth that its backers promise?


    ROBERT J. BARRO | How US Corporate Tax Reform Will Boost Growth

    JASON FURMAN & LAWRENCE H. SUMMERS | Robert Barro's Tax Reform Advocacy: A Response

  3. Murdoch's Last Stand?

    Rupert Murdoch’s sale of 21st Century Fox’s entertainment assets to Disney for $66 billion may mark the end of the media mogul’s career, which will long be remembered for its corrosive effect on democratic discourse on both sides of the Atlantic. 

    From enabling the rise of Donald Trump to hacking the telephone of a murdered British schoolgirl, Murdoch’s media empire has staked its success on stoking populist rage.

  4. Bank of England Leon Neal/Getty Images

    The Dangerous Delusion of Price Stability

    Since the hyperinflation of the 1970s, which central banks were right to combat by whatever means necessary, maintaining positive but low inflation has become a monetary-policy obsession. But, because the world economy has changed dramatically since then, central bankers have started to miss the monetary-policy forest for the trees.

  5. Harvard’s Jeffrey Frankel Measures the GOP’s Tax Plan

    Jeffrey Frankel, a professor at Harvard University’s Kennedy School of Government and a former member of President Bill Clinton’s Council of Economic Advisers, outlines the five criteria he uses to judge the efficacy of tax reform efforts. And in his view, the US Republicans’ most recent offering fails miserably.

  6. A box containing viles of human embryonic Stem Cell cultures Sandy Huffaker/Getty Images

    The Holy Grail of Genetic Engineering

    CRISPR-Cas – a gene-editing technique that is far more precise and efficient than any that has come before it – is poised to change the world. But ensuring that those changes are positive – helping to fight tumors and mosquito-borne illnesses, for example – will require scientists to apply the utmost caution.

  7. The Year Ahead 2018

    The world’s leading thinkers and policymakers examine what’s come apart in the past year, and anticipate what will define the year ahead.

    Order now